Danielle Farris

Danielle Farris supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing critical procurement activities that enable public health surveillance, laboratory diagnostics, and biomedical research. She oversees the acquisition of specialized scientific equipment, diagnostic testing systems, and analytical services essential to CDC’s mission of detecting and responding to infectious disease threats. Her work ensures timely access to high-integrity laboratory instruments, clinical testing capabilities, and data-driven public health tools, aligning procurement strategy with national health security priorities. She routinely handles complex, high-stakes contracts requiring compliance with federal regulatory standards and technical specifications for medical and analytical devices. Farris maintains strategic relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, Cepheid, MRIGLOBAL, and the New York City Health & Hospitals Corporation. These partnerships reflect a focus on high-capacity diagnostic manufacturers, biomedical research providers, and large-scale public health service operators. Her contracting approach emphasizes performance-based requirements, technical validation, and supply chain resilience, often involving long-term service agreements and specialized procurement vehicles to support rapid deployment during public health emergencies. Her procurement portfolio is overwhelmingly non-set-aside, with 86.3% of awards issued under full and open competition, reflecting the technical complexity and scale of required solutions. Nevertheless, she consistently supports small business participation, with approximately 11.8% of awards designated as total small business set-asides and 2.0% allocated to women-owned small businesses, demonstrating a balanced commitment to market diversity without compromising mission-critical capabilities. Farris’s primary NAICS focus areas include analytical laboratory instrument manufacturing, testing laboratories and services, and physician office services, underscoring her expertise in procuring diagnostic equipment, clinical testing infrastructure, and public health analytics platforms. She specializes in acquiring precision instruments for pathogen detection, automated molecular testing systems, and data integration tools that support real-time epidemiological monitoring and laboratory network coordination across federal and state health agencies.